You must also meet at least one of the following body mass index (BMI) requirements at the time you start GLP-1 therapy: A BMI of 35 or higher A BMI between 3034.99 with at least one qualifying condition, such as diastolic heart failure, uncontrolled high blood pressure, chronic kidney disease at stage 3a or higher, prediabetes, a previous heart attack or stroke, or peripheral artery disease with symptoms A BMI between 2729.99 with prediabetes, a previous heart attack or stroke, or peripheral artery disease with symptoms Who does NOT qualify
The article says published literature on GLP-1 agonists in breastfeeding is extremely limited, most prescribing information states lactation data is unavailable, and there are no large human trials
Immediate improvement is often noticed within the first month, although a small subset of patients may experience a mild flare of their acne
Shortly after IGF-1-containing products became more readily available, average 100 m and 200 m sprint times of elite athletes began to significantly decrease [96]
